Skip to main content

and
  1. Article

    Open Access

    Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade

    Immune checkpoint blockade (ICB) has demonstrated efficacy in patients with melanoma, but many exhibit poor responses. Using single cell RNA sequencing of melanoma patient-derived circulating tumor cells (CTCs...

    Douglas B. Fox, Richard Y. Ebright, **n Hong, Hunter C. Russell in npj Precision Oncology (2023)

  2. No Access

    Protocol

    Negative-Selection Enrichment of Circulating Tumor Cells from Peripheral Blood Using the Microfluidic CTC-iChip

    The ability to isolate and analyze rare circulating tumor cells (CTCs) holds the potential to increase our understanding of cancer evolution and allows monitoring of disease and therapeutic responses through a...

    Risa Burr, Jon F. Edd, Brian Chirn, Avanish Mishra, Daniel A. Haber in Mammary Stem Cells (2022)

  3. No Access

    Chapter

    Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring

    Circulating tumor cells (CTCs) provide valuable information about the molecular evolution of cancers, as they may initially respond and ultimately progress on therapy. As intact tumor cells isolated from the b...

    Mark Kalinich, Tanya T. Kwan, Mehmet Toner, Daniel A. Haber in Tumor Liquid Biopsies (2020)

  4. No Access

    Chapter

    Epithelial-Mesenchymal Plasticity in Circulating Tumor Cells, the Precursors of Metastasis

    Circulating tumor cells offer an unprecedented window into the metastatic cascade, and to some extent can be considered as intermediates in the process of metastasis. They exhibit dynamic oscillations in epith...

    Risa Burr, Christine Gilles in Circulating Tumor Cells in Breast Cancer M… (2020)

  5. Article

    Open Access

    Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer

    Plasma genoty** identifies potentially actionable mutations at variable mutant allele frequencies, often admixed with multiple subclonal variants, highlighting the need for their clinical and functional vali...

    Arielle J. Medford, Taronish D. Dubash, Dejan Juric, Laura Spring in npj Precision Oncology (2019)

  6. Article

    Open Access

    Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication

    Homeobox B9 (HOXB9), a transcriptional factor, regulates developmental processes and tumor progression and has recently been recognized as one of important transcriptional factors related to angiogenesis. This...

    Yoshinori Hoshino, Tetsu Hayashida, Akira Hirata, Hidena Takahashi in Molecular Cancer (2014)

  7. No Access

    Article

    The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

    Chromosomal translocations resulting in chimaeric transcription factors underlie specific malignancies, but few authentic target genes regulated by these fusion proteins have been identified. Desmoplastic smal...

    Sean Bong Lee, Kathryn Ann Kolquist, Kim Nichols, Christoph Englert in Nature Genetics (1997)

  8. No Access

    Article

    The Wilms tumour gene WT1 is expressed in murine mesoderm–derived tissues and mutated in a human mesothelioma

    The tumour suppressor gene WT1 encodes a transcription factor expressed in tissues of the genito–urinary system. Inactivation of this gene is associated with the development of Wilms tumour a pediatric kidney ...

    Seon Park, Martin Schalling, Amy Bernard, Shyamala Maheswaran in Nature Genetics (1993)